| Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations G Sauter, JA Lee, JM Bartlett, DJ Slamon, P MF Journal of Clinical Oncology 27 (8), 1323-1333, 2009 | 652 | 2009 |
| Primary care physicians' challenges in ordering clinical laboratory tests and interpreting results J Hickner, PJ Thompson, T Wilkinson, P Epner, M Shaheen, AM Pollock, ... The Journal of the American Board of Family Medicine 27 (2), 268-274, 2014 | 201 | 2014 |
| Patient-reported underuse of prescription medications: a comparison of nine surveys DM Kirking, JA Lee, JJ Ellis, B Briesacher, PL McKercher Medical Care Research and Review 63 (4), 427-446, 2006 | 45 | 2006 |
| Validation of the Academy/ASPEN malnutrition clinical characteristics RK Hand, WJ Murphy, LB Field, JA Lee, JS Parrott, M Ferguson, ... Journal of the Academy of Nutrition and Dietetics 116 (5), 856-864, 2016 | 41 | 2016 |
| Cancer care cost trends in the U nited S tates: 1998 to 2012 JA Lee, CS Roehrig, ED Butto Cancer 122 (7), 1078-1084, 2016 | 29 | 2016 |
| Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives. JA Lee, L Bubendorf, S Rolf, S Peters Expert Review of Anticancer Therapy 13 (5), 625-636, 2013 | 29 | 2013 |
| Comparing Health Care Financial Burden with an Alternative Measure of Unaffordability ES Kielb, CN Rhyan, JA Lee Inquiry: The Journal of Health Care Organization, Provision and Financing …, 2017 | 21 | 2017 |
| Prescription drug use among elderly and nonelderly families PL McKercher, SD Taylor, JA Lee, J Chao, RN Kumar Journal of Managed Care Pharmacy 9 (1), 19-28, 2003 | 21 | 2003 |
| Clinical and health economic outcomes of alternative HER2 test strategies for guiding adjuvant trastuzumab therapy. JA Lee, M Shaheen, T Walke, M Daly Expert Review of Pharmacoeconomics & Outcomes Research 11 (3), 325-341, 2011 | 19 | 2011 |
| A generalized health economic and outcomes research model for the evaluation of companion diagnostics and targeted therapies JA Lee, E Tollefson, M Daly, E Kielb Expert Review of Pharmacoeconomics & Outcomes Research 13 (3), 361-370, 2013 | 16 | 2013 |
| The effects of multiple chronic conditions on adult patient readmissions and hospital finances: A management case study M Mihailoff, S Deb, JA Lee, J Lynn INQUIRY: The Journal of Health Care Organization, Provision, and Financing …, 2017 | 14 | 2017 |
| An Introduction to Economic Analysis of Food Security and Nutrition Interventions K Adams, JA Lee, E Piltch, E Jimenez Journal of the Academy of Nutrition and Dietetics, 2019 | 10 | 2019 |
| Economic analysis of a diabetes-specific nutritional meal replacement for patients with type 2 diabetes S Randolph, V Mustad, J Lee, J Sun Asian Pacific Journal of Clinical Nutrition 1 (19), 2010 | 9 | 2010 |
| Making it safe to grow old: a financial simulation model for launching MediCaring Communities for frail elderly Medicare beneficiaries AK Bernhardt, J Lynn, G Berger, JA Lee, K Reuter, J Davanzo, ... The Milbank Quarterly 94 (3), 597-625, 2016 | 8 | 2016 |
| Statistical comparison of consumer drug expenditures and discretionary purchases to assess drug affordability JA Lee, PL McKercher Clinical Therapeutics 6, 1003-1016, 2002 | 8 | 2002 |
| Reply to EH Hammond et al G Sauter, J Lee, DJ Slamon, MF Press Journal of Clinical Oncology 27 (30), e155-e157, 2009 | 6 | 2009 |
| Reply to V. Arena et al G Sauter, J Lee, JMS Bartlett, DJ Slamon, MF Press Journal of Clinical Oncology 27 (19), e9-e10, 2009 | 2 | 2009 |
| Cost analysis in nutrition-intervention outcomes studies. CS Roehrig, JA Lee Nutrition (Burbank, Los Angeles County, Calif.) 12 (7-8), 558-559, 1996 | 2 | 1996 |
John BartlettDirector of Transformative Pathology, Ontario Institute for Cancer Research在 oicr.on.ca 的电子邮件经过验证
